Representative before the EPO

Research organisation logo thumb
operating since 1968
Headquarter in Barcelona and 1 office
Technology Company

We have observed 2 EP applications Xavier Vallvé Sánchez has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12190483

Neuroprotective multi-target directed drugs

IPC classification:
A61K 31/4545, A61P 25/28, C07D 401/12
Applicant:
Universitat Autònoma de Barcelona (UAB)
Applicant:
Okayama University
Applicant:
Consejo Superior De Investigaciones Científicas (CSIC)
Applicant:
Universidad de Alcalá
Agent:
Xavier Vallvé Sánchez, Universitat Autònoma de Barcelona (UAB)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15186045

PEPTIDE FOR USE IN THE TREATMENT OF DISEASE CAUSED BY CLOSTRIDIUM NEUROTOXINS

IPC classification:
A61K 38/00
Applicant:
Universitat Autònoma de Barcelona (UAB)
Agent:
Xavier Vallvé Sánchez, Universitat Autònoma de Barcelona (UAB)
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature